[N-MeIle4]-cyclosporin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug Name[N-MeIle4]-cyclosporin
Drug Alias NameSDZ-811SDZNIM-811NIM-811
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclophilin B inhibitorsCyclophilin A inhibitors
TargetsCyclophilin ACyclophilin B
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesTaiwan +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgBeijing Novartis Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C, ChronicHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A